and of course GERN. I did sell it a month ago at higher prices than today's, but certainly wish I'd gone back in last week. I have trouble getting back into stocks that were lucky escapes. Too often they seem to coming roaring back, to mock me.
<CRXA. Should I chase it, or be patient?> Don't chase it. CRXA/CLTR have been publishing nice research since the beginning of time, its seems like. It doesn't mean management has even figured the right amount of postage to put on a letter to the FDA.